Early acute kidney injury and sepsis: a multicentre evaluation
Introduction We conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis. Methods The study was a retrospective interrogation of prospectively collected data from the Australian New Zealand Intensive Care Society Adult Patient D...
Uloženo v:
| Vydáno v: | Critical care (London, England) Ročník 12; číslo 2; s. R47 |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
BioMed Central
01.01.2008
BioMed Central Ltd National Library of Medicine - MEDLINE Abstracts |
| Témata: | |
| ISSN: | 1364-8535, 1466-609X, 1364-8535, 1466-609X |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Introduction
We conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis.
Methods
The study was a retrospective interrogation of prospectively collected data from the Australian New Zealand Intensive Care Society Adult Patient Database. Data were collected from 57 intensive care units (ICUs) across Australia. In total, 120,123 patients admitted to ICU for more than 24 hours from 1 January 2000 to 31 December 2005 were included in the analysis. The main outcome measures were clinical and laboratory data and outcomes.
Results
Of 120,123 patients admitted, 33,375 had a sepsis-related diagnosis (27.8%). Among septic patients, 14,039 (42.1%) had concomitant AKI (septic AKI). Sepsis accounted for 32.4% of all patients with AKI. For septic AKI stratified by RIFLE (risk of renal failure, injury to the kidney, failure of kidney function, loss of kidney function and end-stage kidney disease) category, 38.5% of patients belonged to the risk category, 38.8% to the injury category and 22.7% to the failure category. Septic AKI patients had greater acuity of illness (
P
< 0.0001), lower blood pressure (
P
< 0.0001), higher heart rates (
P
< 0.0001), worse pulmonary function measures by arterial oxygen tension/fraction of inspired oxygen ratio (
P
< 0.0001), greater acidaemia (
P
< 0.0001) and higher white cell counts (
P
< 0.0001) compared with patients with nonseptic AKI. Septic AKI was also associated with greater severity of AKI (RIFLE category injury or failure) compared with nonseptic AKI. Septic AKI was associated with a significantly higher crude and co-variate adjusted mortality in the ICU (19.8% versus 13.4%; odds ratio 1.60, 95% confidence interval 1.5 to 1.7;
P
< 0.001) and in hospital (29.7% versus 21.6%; odds ratio 1.53, 95% confidence interval 1.46 to 1.60;
P
< 0.001) compared with nonseptic AKI. Septic AKI was associated with higher ICU and hospital mortality across all strata of RIFLE categories. Septic AKI patients had longer durations of stay in both ICU and hospital across all strata of RIFLE categories.
Conclusion
Septic AKI is common during the first 24 hours after ICU admission. Patients with septic AKI are generally sicker, with a higher burden of illness, and have greater abnormalities in acute physiology compared with patients with nonseptic AKI. Moreover, septic AKI is independently associated with higher odds of death and longer duration of hospitalization. |
|---|---|
| AbstractList | We conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis.
The study was a retrospective interrogation of prospectively collected data from the Australian New Zealand Intensive Care Society Adult Patient Database. Data were collected from 57 intensive care units (ICUs) across Australia. In total, 120,123 patients admitted to ICU for more than 24 hours from 1 January 2000 to 31 December 2005 were included in the analysis. The main outcome measures were clinical and laboratory data and outcomes.
Of 120,123 patients admitted, 33,375 had a sepsis-related diagnosis (27.8%). Among septic patients, 14,039 (42.1%) had concomitant AKI (septic AKI). Sepsis accounted for 32.4% of all patients with AKI. For septic AKI stratified by RIFLE (risk of renal failure, injury to the kidney, failure of kidney function, loss of kidney function and end-stage kidney disease) category, 38.5% of patients belonged to the risk category, 38.8% to the injury category and 22.7% to the failure category. Septic AKI patients had greater acuity of illness (P < 0.0001), lower blood pressure (P < 0.0001), higher heart rates (P < 0.0001), worse pulmonary function measures by arterial oxygen tension/fraction of inspired oxygen ratio (P < 0.0001), greater acidaemia (P < 0.0001) and higher white cell counts (P < 0.0001) compared with patients with nonseptic AKI. Septic AKI was also associated with greater severity of AKI (RIFLE category injury or failure) compared with nonseptic AKI. Septic AKI was associated with a significantly higher crude and co-variate adjusted mortality in the ICU (19.8% versus 13.4%; odds ratio 1.60, 95% confidence interval 1.5 to 1.7; P < 0.001) and in hospital (29.7% versus 21.6%; odds ratio 1.53, 95% confidence interval 1.46 to 1.60; P < 0.001) compared with nonseptic AKI. Septic AKI was associated with higher ICU and hospital mortality across all strata of RIFLE categories. Septic AKI patients had longer durations of stay in both ICU and hospital across all strata of RIFLE categories.
Septic AKI is common during the first 24 hours after ICU admission. Patients with septic AKI are generally sicker, with a higher burden of illness, and have greater abnormalities in acute physiology compared with patients with nonseptic AKI. Moreover, septic AKI is independently associated with higher odds of death and longer duration of hospitalization. We conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis. The study was a retrospective interrogation of prospectively collected data from the Australian New Zealand Intensive Care Society Adult Patient Database. Data were collected from 57 intensive care units (ICUs) across Australia. In total, 120,123 patients admitted to ICU for more than 24 hours from 1 January 2000 to 31 December 2005 were included in the analysis. The main outcome measures were clinical and laboratory data and outcomes. Of 120,123 patients admitted, 33,375 had a sepsis-related diagnosis (27.8%). Among septic patients, 14,039 (42.1%) had concomitant AKI (septic AKI). Sepsis accounted for 32.4% of all patients with AKI. For septic AKI stratified by RIFLE (risk of renal failure, injury to the kidney, failure of kidney function, loss of kidney function and end-stage kidney disease) category, 38.5% of patients belonged to the risk category, 38.8% to the injury category and 22.7% to the failure category. Septic AKI patients had greater acuity of illness (P < 0.0001), lower blood pressure (P < 0.0001), higher heart rates (P < 0.0001), worse pulmonary function measures by arterial oxygen tension/fraction of inspired oxygen ratio (P < 0.0001), greater acidaemia (P < 0.0001) and higher white cell counts (P < 0.0001) compared with patients with nonseptic AKI. Septic AKI was also associated with greater severity of AKI (RIFLE category injury or failure) compared with nonseptic AKI. Septic AKI was associated with a significantly higher crude and co-variate adjusted mortality in the ICU (19.8% versus 13.4%; odds ratio 1.60, 95% confidence interval 1.5 to 1.7; P < 0.001) and in hospital (29.7% versus 21.6%; odds ratio 1.53, 95% confidence interval 1.46 to 1.60; P < 0.001) compared with nonseptic AKI. Septic AKI was associated with higher ICU and hospital mortality across all strata of RIFLE categories. Septic AKI patients had longer durations of stay in both ICU and hospital across all strata of RIFLE categories. Septic AKI is common during the first 24 hours after ICU admission. Patients with septic AKI are generally sicker, with a higher burden of illness, and have greater abnormalities in acute physiology compared with patients with nonseptic AKI. Moreover, septic AKI is independently associated with higher odds of death and longer duration of hospitalization. We conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis.INTRODUCTIONWe conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis.The study was a retrospective interrogation of prospectively collected data from the Australian New Zealand Intensive Care Society Adult Patient Database. Data were collected from 57 intensive care units (ICUs) across Australia. In total, 120,123 patients admitted to ICU for more than 24 hours from 1 January 2000 to 31 December 2005 were included in the analysis. The main outcome measures were clinical and laboratory data and outcomes.METHODSThe study was a retrospective interrogation of prospectively collected data from the Australian New Zealand Intensive Care Society Adult Patient Database. Data were collected from 57 intensive care units (ICUs) across Australia. In total, 120,123 patients admitted to ICU for more than 24 hours from 1 January 2000 to 31 December 2005 were included in the analysis. The main outcome measures were clinical and laboratory data and outcomes.Of 120,123 patients admitted, 33,375 had a sepsis-related diagnosis (27.8%). Among septic patients, 14,039 (42.1%) had concomitant AKI (septic AKI). Sepsis accounted for 32.4% of all patients with AKI. For septic AKI stratified by RIFLE (risk of renal failure, injury to the kidney, failure of kidney function, loss of kidney function and end-stage kidney disease) category, 38.5% of patients belonged to the risk category, 38.8% to the injury category and 22.7% to the failure category. Septic AKI patients had greater acuity of illness (P < 0.0001), lower blood pressure (P < 0.0001), higher heart rates (P < 0.0001), worse pulmonary function measures by arterial oxygen tension/fraction of inspired oxygen ratio (P < 0.0001), greater acidaemia (P < 0.0001) and higher white cell counts (P < 0.0001) compared with patients with nonseptic AKI. Septic AKI was also associated with greater severity of AKI (RIFLE category injury or failure) compared with nonseptic AKI. Septic AKI was associated with a significantly higher crude and co-variate adjusted mortality in the ICU (19.8% versus 13.4%; odds ratio 1.60, 95% confidence interval 1.5 to 1.7; P < 0.001) and in hospital (29.7% versus 21.6%; odds ratio 1.53, 95% confidence interval 1.46 to 1.60; P < 0.001) compared with nonseptic AKI. Septic AKI was associated with higher ICU and hospital mortality across all strata of RIFLE categories. Septic AKI patients had longer durations of stay in both ICU and hospital across all strata of RIFLE categories.RESULTSOf 120,123 patients admitted, 33,375 had a sepsis-related diagnosis (27.8%). Among septic patients, 14,039 (42.1%) had concomitant AKI (septic AKI). Sepsis accounted for 32.4% of all patients with AKI. For septic AKI stratified by RIFLE (risk of renal failure, injury to the kidney, failure of kidney function, loss of kidney function and end-stage kidney disease) category, 38.5% of patients belonged to the risk category, 38.8% to the injury category and 22.7% to the failure category. Septic AKI patients had greater acuity of illness (P < 0.0001), lower blood pressure (P < 0.0001), higher heart rates (P < 0.0001), worse pulmonary function measures by arterial oxygen tension/fraction of inspired oxygen ratio (P < 0.0001), greater acidaemia (P < 0.0001) and higher white cell counts (P < 0.0001) compared with patients with nonseptic AKI. Septic AKI was also associated with greater severity of AKI (RIFLE category injury or failure) compared with nonseptic AKI. Septic AKI was associated with a significantly higher crude and co-variate adjusted mortality in the ICU (19.8% versus 13.4%; odds ratio 1.60, 95% confidence interval 1.5 to 1.7; P < 0.001) and in hospital (29.7% versus 21.6%; odds ratio 1.53, 95% confidence interval 1.46 to 1.60; P < 0.001) compared with nonseptic AKI. Septic AKI was associated with higher ICU and hospital mortality across all strata of RIFLE categories. Septic AKI patients had longer durations of stay in both ICU and hospital across all strata of RIFLE categories.Septic AKI is common during the first 24 hours after ICU admission. Patients with septic AKI are generally sicker, with a higher burden of illness, and have greater abnormalities in acute physiology compared with patients with nonseptic AKI. Moreover, septic AKI is independently associated with higher odds of death and longer duration of hospitalization.CONCLUSIONSeptic AKI is common during the first 24 hours after ICU admission. Patients with septic AKI are generally sicker, with a higher burden of illness, and have greater abnormalities in acute physiology compared with patients with nonseptic AKI. Moreover, septic AKI is independently associated with higher odds of death and longer duration of hospitalization. Introduction We conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis. Methods The study was a retrospective interrogation of prospectively collected data from the Australian New Zealand Intensive Care Society Adult Patient Database. Data were collected from 57 intensive care units (ICUs) across Australia. In total, 120,123 patients admitted to ICU for more than 24 hours from 1 January 2000 to 31 December 2005 were included in the analysis. The main outcome measures were clinical and laboratory data and outcomes. Results Of 120,123 patients admitted, 33,375 had a sepsis-related diagnosis (27.8%). Among septic patients, 14,039 (42.1%) had concomitant AKI (septic AKI). Sepsis accounted for 32.4% of all patients with AKI. For septic AKI stratified by RIFLE (risk of renal failure, injury to the kidney, failure of kidney function, loss of kidney function and end-stage kidney disease) category, 38.5% of patients belonged to the risk category, 38.8% to the injury category and 22.7% to the failure category. Septic AKI patients had greater acuity of illness (P & 0.0001), lower blood pressure (P & 0.0001), higher heart rates (P & 0.0001), worse pulmonary function measures by arterial oxygen tension/fraction of inspired oxygen ratio (P & 0.0001), greater acidaemia (P & 0.0001) and higher white cell counts (P & 0.0001) compared with patients with nonseptic AKI. Septic AKI was also associated with greater severity of AKI (RIFLE category injury or failure) compared with nonseptic AKI. Septic AKI was associated with a significantly higher crude and co-variate adjusted mortality in the ICU (19.8% versus 13.4%; odds ratio 1.60, 95% confidence interval 1.5 to 1.7; P & 0.001) and in hospital (29.7% versus 21.6%; odds ratio 1.53, 95% confidence interval 1.46 to 1.60; P & 0.001) compared with nonseptic AKI. Septic AKI was associated with higher ICU and hospital mortality across all strata of RIFLE categories. Septic AKI patients had longer durations of stay in both ICU and hospital across all strata of RIFLE categories. Conclusion Septic AKI is common during the first 24 hours after ICU admission. Patients with septic AKI are generally sicker, with a higher burden of illness, and have greater abnormalities in acute physiology compared with patients with nonseptic AKI. Moreover, septic AKI is independently associated with higher odds of death and longer duration of hospitalization. Introduction We conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis. Methods The study was a retrospective interrogation of prospectively collected data from the Australian New Zealand Intensive Care Society Adult Patient Database. Data were collected from 57 intensive care units (ICUs) across Australia. In total, 120,123 patients admitted to ICU for more than 24 hours from 1 January 2000 to 31 December 2005 were included in the analysis. The main outcome measures were clinical and laboratory data and outcomes. Results Of 120,123 patients admitted, 33,375 had a sepsis-related diagnosis (27.8%). Among septic patients, 14,039 (42.1%) had concomitant AKI (septic AKI). Sepsis accounted for 32.4% of all patients with AKI. For septic AKI stratified by RIFLE (risk of renal failure, injury to the kidney, failure of kidney function, loss of kidney function and end-stage kidney disease) category, 38.5% of patients belonged to the risk category, 38.8% to the injury category and 22.7% to the failure category. Septic AKI patients had greater acuity of illness ( P < 0.0001), lower blood pressure ( P < 0.0001), higher heart rates ( P < 0.0001), worse pulmonary function measures by arterial oxygen tension/fraction of inspired oxygen ratio ( P < 0.0001), greater acidaemia ( P < 0.0001) and higher white cell counts ( P < 0.0001) compared with patients with nonseptic AKI. Septic AKI was also associated with greater severity of AKI (RIFLE category injury or failure) compared with nonseptic AKI. Septic AKI was associated with a significantly higher crude and co-variate adjusted mortality in the ICU (19.8% versus 13.4%; odds ratio 1.60, 95% confidence interval 1.5 to 1.7; P < 0.001) and in hospital (29.7% versus 21.6%; odds ratio 1.53, 95% confidence interval 1.46 to 1.60; P < 0.001) compared with nonseptic AKI. Septic AKI was associated with higher ICU and hospital mortality across all strata of RIFLE categories. Septic AKI patients had longer durations of stay in both ICU and hospital across all strata of RIFLE categories. Conclusion Septic AKI is common during the first 24 hours after ICU admission. Patients with septic AKI are generally sicker, with a higher burden of illness, and have greater abnormalities in acute physiology compared with patients with nonseptic AKI. Moreover, septic AKI is independently associated with higher odds of death and longer duration of hospitalization. |
| ArticleNumber | R47 |
| Audience | Academic |
| Author | Bellomo, Rinaldo Bagshaw, Sean M George, Carol |
| AuthorAffiliation | 1 Division of Critical Care Medicine, Faculty of Medicine and Dentistry, 3C1.12 Walter C Mackenzie Centrel, University of Alberta Hospital, University of Alberta, 8440-112 St NW, Edmonton, Alberta, T6G2B7 Canada 2 Department of Intensive Care, Austin Hospital, Melbourne, Australia 4 Department of Medicine, Melbourne University, Grattan St, Melbourne, Australia 3052 3 Australia New Zealand Intensive Care Society (ANZICS) Adult Patient Database (APD), 10 Ievers St, Melbourne, Australia 3052 |
| AuthorAffiliation_xml | – name: 1 Division of Critical Care Medicine, Faculty of Medicine and Dentistry, 3C1.12 Walter C Mackenzie Centrel, University of Alberta Hospital, University of Alberta, 8440-112 St NW, Edmonton, Alberta, T6G2B7 Canada – name: 4 Department of Medicine, Melbourne University, Grattan St, Melbourne, Australia 3052 – name: 2 Department of Intensive Care, Austin Hospital, Melbourne, Australia – name: 3 Australia New Zealand Intensive Care Society (ANZICS) Adult Patient Database (APD), 10 Ievers St, Melbourne, Australia 3052 |
| Author_xml | – sequence: 1 givenname: Sean M surname: Bagshaw fullname: Bagshaw, Sean M email: bagshaw@ualberta.ca organization: Division of Critical Care Medicine, University of Alberta Hospital, University of Alberta, Department of Intensive Care, Austin Hospital – sequence: 2 givenname: Carol surname: George fullname: George, Carol organization: Australia New Zealand Intensive Care Society (ANZICS), Adult Patient Database (APD) – sequence: 3 givenname: Rinaldo surname: Bellomo fullname: Bellomo, Rinaldo organization: Department of Intensive Care, Austin Hospital, Department of Medicine, Melbourne University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18402655$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkktv1DAUhS1URB_AT0ARC9h0it-Ju6hUVS0gVWIDa8txrgcPjj3YSaX595iZQqdlgbywdf356Fyfe4wOYoqA0GuCzwjp5AdrZSfZM3REmOSLTjBxsHc-RMelrDAmbYVeoEPScUylEEfo4trksGmMnSdofvghwqbxcTXnWotDU2BdfDlvTDPOYfIW4pShgTsTZjP5FF-i586EAq_u9xP07eb669Wnxe2Xj5-vLm8XVgg1LRTHRhLGlDHOda3rjRUMeqZ4byVwM_Stw5KKvu0E7zEeJOUUDO0sBoldy07QxU53PfcjDFsfJuh19qPJG52M149vov-ul-lOU85boboq8O5eIKefM5RJj75YCMFESHPRUlEpifw_SJQUmElcwbdPwFWac6y_UBnBueKEVuhsBy1NAO2jS9WdrWuA0dsaofO1fllzIZiq7YM3-43-7fBPYg_-bE6lZHAPCNa_R0HvRqGCp09A66dtaNWCD__i73d4qXpxCXmvncfkL9mWwQk |
| CitedBy_id | crossref_primary_10_1007_s00134_009_1724_9 crossref_primary_10_1016_j_bbcan_2012_03_008 crossref_primary_10_1002_phar_2947 crossref_primary_10_1016_j_kint_2016_02_017 crossref_primary_10_1186_cc13803 crossref_primary_10_1016_j_acmx_2015_05_004 crossref_primary_10_3390_vaccines11020464 crossref_primary_10_1186_cc11860 crossref_primary_10_1164_rccm_200902_0207UP crossref_primary_10_1002_kjm2_12255 crossref_primary_10_1186_s13054_021_03538_0 crossref_primary_10_2215_CJN_05480610 crossref_primary_10_1159_000368902 crossref_primary_10_4103_cjp_cjp_16_21 crossref_primary_10_3389_fphar_2019_01323 crossref_primary_10_1097_SHK_0000000000001768 crossref_primary_10_1093_eurjhf_hfp169 crossref_primary_10_1164_rccm_201911_2187OC crossref_primary_10_1177_2054358117703985 crossref_primary_10_18621_eurj_1495394 crossref_primary_10_1097_SHK_0000000000001883 crossref_primary_10_1007_s40620_016_0359_5 crossref_primary_10_1155_2013_479730 crossref_primary_10_1016_j_thromres_2017_01_004 crossref_primary_10_1097_EJA_0b013e32832d543d crossref_primary_10_1186_s40635_017_0118_5 crossref_primary_10_1007_s00467_020_04557_9 crossref_primary_10_5194_jsss_9_251_2020 crossref_primary_10_1159_000513742 crossref_primary_10_3390_ijms25115924 crossref_primary_10_1186_1471_2369_12_43 crossref_primary_10_1186_1745_6215_15_270 crossref_primary_10_1515_cclm_2012_0822 crossref_primary_10_1136_bmjopen_2020_040718 crossref_primary_10_1080_0886022X_2022_2081180 crossref_primary_10_1186_cc10517 crossref_primary_10_1186_s12879_024_10179_5 crossref_primary_10_5194_jsss_7_559_2018 crossref_primary_10_1007_s00134_009_1711_1 crossref_primary_10_1097_ALN_0000000000000446 crossref_primary_10_3810_pgm_2013_11_2715 crossref_primary_10_1016_j_jcrc_2015_09_017 crossref_primary_10_1016_j_jcrc_2010_07_006 crossref_primary_10_1177_87564793221078835 crossref_primary_10_1097_CCM_0000000000002007 crossref_primary_10_23876_j_krcp_24_061 crossref_primary_10_1093_ofid_ofae059 crossref_primary_10_1097_CCM_0000000000005885 crossref_primary_10_1111_1744_9987_13826 crossref_primary_10_1097_CCM_0000000000000194 crossref_primary_10_1093_ndt_gfn679 crossref_primary_10_1007_s44349_025_00020_6 crossref_primary_10_5867_medwave_2011_05_5028 crossref_primary_10_1194_jlr_M076745 crossref_primary_10_1177_1098612X12464458 crossref_primary_10_1164_rccm_202007_2627ED crossref_primary_10_3892_etm_2018_5808 crossref_primary_10_1177_08850666241268390 crossref_primary_10_1007_s10620_019_05581_y crossref_primary_10_1186_s12882_018_1122_z crossref_primary_10_1186_s13613_016_0162_4 crossref_primary_10_1016_j_kint_2016_03_025 crossref_primary_10_1016_j_ajem_2017_11_055 crossref_primary_10_1111_j_1447_0594_2012_00869_x crossref_primary_10_3892_etm_2014_1781 crossref_primary_10_1007_s11255_020_02499_7 crossref_primary_10_3389_fphar_2020_00790 crossref_primary_10_1016_j_semnephrol_2020_08_005 crossref_primary_10_1016_j_krcp_2014_11_002 crossref_primary_10_1186_s12882_017_0586_6 crossref_primary_10_1111_jcmm_16934 crossref_primary_10_1016_j_ijantimicag_2016_12_022 crossref_primary_10_1002_phar_2852 crossref_primary_10_1016_S0140_6736_15_60266_5 crossref_primary_10_1080_0886022X_2024_2436106 crossref_primary_10_1007_s00134_015_3827_9 crossref_primary_10_1111_1744_9987_13928 crossref_primary_10_1164_rccm_201511_2285OC crossref_primary_10_1186_s10020_024_00964_y crossref_primary_10_1681_ASN_2017060624 crossref_primary_10_3390_jpm12010043 crossref_primary_10_1016_j_nephro_2021_03_003 crossref_primary_10_1186_s13613_015_0095_3 crossref_primary_10_1186_s13054_025_05351_5 crossref_primary_10_3892_br_2015_427 crossref_primary_10_3892_etm_2011_339 crossref_primary_10_3389_fmed_2022_1015735 crossref_primary_10_3389_fgene_2022_1062293 crossref_primary_10_1177_20503121251333691 crossref_primary_10_1093_ndt_gfv366 crossref_primary_10_1186_cc10554 crossref_primary_10_1186_s12882_018_0895_4 crossref_primary_10_4061_2011_351291 crossref_primary_10_4103_0972_5229_112147 crossref_primary_10_1111_ped_13359 crossref_primary_10_1007_s10157_018_1600_4 crossref_primary_10_1080_14787210_2020_1764845 crossref_primary_10_1186_cc13708 crossref_primary_10_1038_s41598_025_04579_z crossref_primary_10_1007_s10753_019_01144_5 crossref_primary_10_1186_s12882_023_03150_0 crossref_primary_10_1093_eurheartj_ehp507 crossref_primary_10_1007_s00134_018_5224_7 crossref_primary_10_1111_nep_14246 crossref_primary_10_1097_CCM_0000000000004872 crossref_primary_10_2147_IJNRD_S524082 crossref_primary_10_1097_CCM_0000000000004511 crossref_primary_10_1111_nep_13164 crossref_primary_10_1371_journal_pone_0259777 crossref_primary_10_1007_s00467_017_3732_2 crossref_primary_10_1111_apha_14025 crossref_primary_10_1016_j_ajem_2018_05_012 crossref_primary_10_12688_f1000research_74540_2 crossref_primary_10_1186_cc11419 crossref_primary_10_12688_f1000research_74540_1 crossref_primary_10_1186_s13054_017_1815_x crossref_primary_10_3390_nu8030165 crossref_primary_10_1186_cc13716 crossref_primary_10_1016_j_nephro_2021_07_324 crossref_primary_10_1186_s40560_025_00776_0 crossref_primary_10_1371_journal_pone_0035838 crossref_primary_10_1038_ki_2014_293 crossref_primary_10_1186_cc10252 crossref_primary_10_1016_j_jss_2015_12_011 crossref_primary_10_1016_j_jcrc_2018_08_004 crossref_primary_10_1093_ckj_sfw107 crossref_primary_10_1681_ASN_2013111215 crossref_primary_10_1097_CCM_0000000000002878 crossref_primary_10_1007_s00063_015_0093_0 crossref_primary_10_1016_j_cger_2012_10_007 crossref_primary_10_3389_fmed_2022_890782 crossref_primary_10_1007_s11255_014_0747_5 crossref_primary_10_2169_naika_99_918 crossref_primary_10_1007_s10753_021_01507_x crossref_primary_10_1590_S1807_59322010000800006 crossref_primary_10_3389_fphar_2025_1627253 crossref_primary_10_3389_fimmu_2024_1444740 crossref_primary_10_1517_14740338_2015_1085504 crossref_primary_10_1161_CIRCULATIONAHA_115_019955 crossref_primary_10_1186_s13017_018_0202_5 crossref_primary_10_1016_j_jcrc_2022_154150 crossref_primary_10_1038_s41581_023_00683_3 crossref_primary_10_1089_gtmb_2019_0222 crossref_primary_10_1007_s40262_018_0636_7 crossref_primary_10_1080_0886022X_2024_2325640 crossref_primary_10_3390_diagnostics11081518 crossref_primary_10_1007_s00431_012_1854_x crossref_primary_10_1016_j_jcrc_2014_04_003 crossref_primary_10_3390_jcm9061704 crossref_primary_10_5527_wjn_v7_i8_148 crossref_primary_10_1016_j_xkme_2021_02_007 crossref_primary_10_3389_fimmu_2022_905601 crossref_primary_10_1038_s41598_025_10776_7 crossref_primary_10_7759_cureus_75992 crossref_primary_10_1155_2014_203637 crossref_primary_10_1080_0886022X_2023_2185084 crossref_primary_10_3389_fmed_2023_1324369 crossref_primary_10_1080_03639045_2024_2434958 crossref_primary_10_1111_sdi_12972 crossref_primary_10_1080_0886022X_2017_1419970 crossref_primary_10_1038_s41598_025_96320_z crossref_primary_10_1111_1744_9987_13895 crossref_primary_10_1080_17512433_2021_1978287 crossref_primary_10_1186_s12879_023_08045_x crossref_primary_10_1007_s00467_013_2427_6 crossref_primary_10_1186_s12882_017_0587_5 crossref_primary_10_3390_nano10040712 crossref_primary_10_1016_j_heliyon_2024_e29257 crossref_primary_10_1177_0310057X1103900307 crossref_primary_10_1016_j_ccm_2016_01_012 crossref_primary_10_1016_j_jtcvs_2009_07_007 crossref_primary_10_1080_0886022X_2020_1761832 crossref_primary_10_1111_j_1742_1241_2012_02939_x crossref_primary_10_1080_08998280_2016_11929342 crossref_primary_10_3390_ph15070899 crossref_primary_10_1111_1440_1681_12031 crossref_primary_10_3892_mmr_2022_12612 crossref_primary_10_3390_biomedicines10020264 crossref_primary_10_1038_nrneph_2009_234 crossref_primary_10_1007_s00467_020_04704_2 crossref_primary_10_1186_s13613_020_0648_y crossref_primary_10_1177_0885066616645308 crossref_primary_10_3389_fmed_2022_789623 crossref_primary_10_1097_MD_0000000000016800 crossref_primary_10_3389_fimmu_2024_1382003 crossref_primary_10_1155_2016_8219287 crossref_primary_10_3109_0886022X_2014_945184 crossref_primary_10_1136_bcr_2015_212028 crossref_primary_10_1097_TA_0b013e3181c4539f crossref_primary_10_1186_1471_2369_11_9 crossref_primary_10_1186_s12879_025_10649_4 crossref_primary_10_1038_s41598_017_10271_8 crossref_primary_10_1097_CCE_0000000000001010 crossref_primary_10_1164_rccm_201401_0077OC crossref_primary_10_1186_s41100_018_0182_7 crossref_primary_10_3390_jcm7090274 crossref_primary_10_1038_s41390_019_0698_8 crossref_primary_10_3892_mmr_2020_11001 crossref_primary_10_1186_s40560_016_0146_3 crossref_primary_10_1016_j_jcrc_2015_06_021 crossref_primary_10_3390_jcm12196388 crossref_primary_10_1111_j_1742_7843_2009_00448_x crossref_primary_10_1007_s11739_016_1407_9 crossref_primary_10_3892_etm_2018_5890 crossref_primary_10_1038_ki_2015_164 crossref_primary_10_1089_sur_2017_261 crossref_primary_10_1007_s00467_014_2757_z crossref_primary_10_1016_j_jbior_2018_11_003 crossref_primary_10_1016_j_nephro_2016_03_003 crossref_primary_10_1097_FTD_0000000000000459 crossref_primary_10_1186_s12882_021_02503_x crossref_primary_10_1007_s00134_011_2167_7 crossref_primary_10_1161_JAHA_116_004509 crossref_primary_10_3390_jcm9010151 crossref_primary_10_1155_2012_856401 crossref_primary_10_1016_j_accpm_2023_101332 crossref_primary_10_1097_HPC_0000000000000214 crossref_primary_10_1097_PCC_0000000000000034 crossref_primary_10_1186_s40560_019_0415_z crossref_primary_10_1007_s40139_013_0023_x crossref_primary_10_1016_j_amjmed_2011_07_010 crossref_primary_10_1111_1744_9987_13854 crossref_primary_10_1186_s13613_018_0468_5 crossref_primary_10_1080_0886022X_2023_2176170 crossref_primary_10_1113_expphysiol_2011_061804 crossref_primary_10_3892_etm_2016_3076 crossref_primary_10_1016_j_jss_2016_08_083 crossref_primary_10_1016_j_jclinane_2014_09_011 crossref_primary_10_1681_ASN_0000000809 crossref_primary_10_1097_CCM_0000000000000305 crossref_primary_10_1007_s00134_010_2089_9 crossref_primary_10_3892_etm_2019_8115 crossref_primary_10_1007_s10753_014_9957_3 crossref_primary_10_1186_cc9014 crossref_primary_10_7759_cureus_37857 crossref_primary_10_1186_s13613_025_01469_5 crossref_primary_10_3389_fmed_2025_1546112 crossref_primary_10_3389_fphar_2021_718089 crossref_primary_10_1186_s13054_019_2386_9 crossref_primary_10_1186_s12882_020_01974_8 crossref_primary_10_1134_S1607672921050033 crossref_primary_10_1515_cclm_2021_0040 crossref_primary_10_1007_s12630_010_9375_4 crossref_primary_10_1016_j_semnephrol_2023_151466 crossref_primary_10_1159_000444094 crossref_primary_10_3390_ijms221910238 crossref_primary_10_1016_j_jcrc_2016_06_004 crossref_primary_10_1016_j_jcrc_2018_03_011 crossref_primary_10_1007_s00431_022_04753_9 crossref_primary_10_1016_j_jcrc_2011_05_017 crossref_primary_10_1007_s10741_010_9223_1 crossref_primary_10_1159_000507999 crossref_primary_10_1080_08923973_2023_2250911 crossref_primary_10_1007_s40620_018_0534_y crossref_primary_10_1007_s00134_008_1367_2 crossref_primary_10_1016_j_ijcard_2016_04_061 crossref_primary_10_1007_s10753_020_01293_y crossref_primary_10_1016_j_jcrc_2014_03_015 crossref_primary_10_1093_ndt_gfq005 crossref_primary_10_1371_journal_pone_0127411 crossref_primary_10_1080_08820139_2018_1493497 crossref_primary_10_1080_13102818_2019_1664929 crossref_primary_10_1111_aas_12133 crossref_primary_10_1002_ams2_70037 crossref_primary_10_3390_jcm10122603 crossref_primary_10_1186_s12967_021_03190_w crossref_primary_10_1016_j_jcrc_2011_04_005 crossref_primary_10_1007_s40620_021_01060_8 crossref_primary_10_1053_j_ajkd_2013_11_027 crossref_primary_10_1016_j_semnephrol_2015_01_002 crossref_primary_10_1016_j_semnephrol_2015_01_003 crossref_primary_10_1097_CCM_0000000000003901 crossref_primary_10_18203_2320_6012_ijrms20252015 crossref_primary_10_3390_jcm13226720 crossref_primary_10_5005_jp_journals_10071_23386 crossref_primary_10_1016_j_clinthera_2016_10_009 crossref_primary_10_1097_CCM_0b013e3182514be9 crossref_primary_10_1097_MD_0000000000007626 crossref_primary_10_1111_vec_12248 crossref_primary_10_1186_s12882_021_02451_6 crossref_primary_10_1097_CNQ_0000000000000553 crossref_primary_10_1111_j_1525_139X_2011_01029_x crossref_primary_10_1016_j_kint_2020_07_047 crossref_primary_10_1097_CCM_0000000000001835 crossref_primary_10_1155_2017_5241482 crossref_primary_10_1371_journal_pone_0208742 crossref_primary_10_1016_j_jcrc_2011_04_009 crossref_primary_10_3892_etm_2022_11490 crossref_primary_10_1111_micc_12483 crossref_primary_10_1186_s12873_022_00589_6 crossref_primary_10_1097_CCE_0000000000000793 crossref_primary_10_1155_2014_172620 crossref_primary_10_1093_jacamr_dlac080 crossref_primary_10_1016_j_metabol_2024_155974 crossref_primary_10_1016_j_jcrc_2018_10_017 crossref_primary_10_1186_cc13161 crossref_primary_10_1097_SHK_0000000000002386 crossref_primary_10_1080_0886022X_2021_1939051 crossref_primary_10_1007_s11255_020_02724_3 crossref_primary_10_1186_s12882_020_1709_z crossref_primary_10_1016_j_jemermed_2024_09_012 crossref_primary_10_1159_000381009 crossref_primary_10_1371_journal_pone_0114312 crossref_primary_10_2147_IJGM_S320768 crossref_primary_10_1111_nep_12521 crossref_primary_10_1016_j_jcrc_2010_04_012 crossref_primary_10_1096_fj_202100174R crossref_primary_10_1152_japplphysiol_00783_2017 crossref_primary_10_1186_s12879_025_10880_z crossref_primary_10_1007_s10753_015_0282_2 crossref_primary_10_1155_2021_6636621 crossref_primary_10_1155_2012_691013 crossref_primary_10_1097_TA_0b013e31828586ec crossref_primary_10_1080_0886022X_2024_2310081 crossref_primary_10_1002_pbc_26915 crossref_primary_10_1016_j_rcl_2019_08_001 crossref_primary_10_1111_nep_12637 crossref_primary_10_1007_s00392_014_0680_8 crossref_primary_10_1007_s11255_014_0878_8 crossref_primary_10_7717_peerj_10122 crossref_primary_10_3390_jcm12093188 crossref_primary_10_3389_fimmu_2022_1060612 crossref_primary_10_1186_1471_2369_16_5 crossref_primary_10_1038_ki_2008_442 crossref_primary_10_2215_CJN_08531109 crossref_primary_10_1016_j_jstrokecerebrovasdis_2012_06_005 crossref_primary_10_1016_j_forsciint_2019_05_034 crossref_primary_10_1097_SHK_0000000000002118 crossref_primary_10_1007_s11033_018_4230_8 crossref_primary_10_7759_cureus_59517 crossref_primary_10_1016_j_pcl_2013_02_006 crossref_primary_10_1111_bph_15363 crossref_primary_10_1007_s00467_018_3981_8 crossref_primary_10_1007_s12630_019_01306_x crossref_primary_10_1016_j_cca_2013_01_014 crossref_primary_10_1186_cc6823 crossref_primary_10_1007_s00228_022_03415_x crossref_primary_10_1038_s41390_022_02269_4 crossref_primary_10_1378_chest_09_3071 crossref_primary_10_1097_SHK_0000000000000967 crossref_primary_10_1097_JCMA_0000000000000404 crossref_primary_10_1186_s41065_021_00176_y crossref_primary_10_1007_s10753_024_02081_8 crossref_primary_10_1177_0310057X1204000604 crossref_primary_10_1186_2110_5820_1_13 crossref_primary_10_3109_0886022X_2012_713254 crossref_primary_10_1016_j_kint_2019_06_023 crossref_primary_10_1186_s41100_018_0177_4 crossref_primary_10_1186_s12882_022_02726_6 crossref_primary_10_1186_s12882_017_0602_x crossref_primary_10_2217_bmm_10_12 crossref_primary_10_1016_j_heliyon_2024_e24227 crossref_primary_10_1080_0886022X_2021_1883652 crossref_primary_10_1080_17425255_2020_1750597 crossref_primary_10_1016_j_etap_2021_103587 crossref_primary_10_7717_peerj_16709 crossref_primary_10_1038_s41598_024_55653_x crossref_primary_10_1016_j_accpm_2018_11_008 crossref_primary_10_1007_s00467_018_3907_5 crossref_primary_10_1016_j_taap_2016_10_015 crossref_primary_10_1016_j_aucc_2015_06_001 crossref_primary_10_23876_j_krcp_23_312 crossref_primary_10_1097_TA_0b013e3181a51a51 crossref_primary_10_1038_nrneph_2013_282 crossref_primary_10_1371_journal_pone_0082250 crossref_primary_10_1080_0886022X_2023_2238828 crossref_primary_10_1016_j_trim_2025_102183 crossref_primary_10_1007_s10047_017_0970_9 crossref_primary_10_1038_nrneph_2011_13 crossref_primary_10_1186_s13054_017_1631_3 crossref_primary_10_3390_jcm7100307 crossref_primary_10_5812_iji_135791 crossref_primary_10_1038_ki_2010_85 crossref_primary_10_1016_j_semnephrol_2016_01_008 crossref_primary_10_1093_ndt_gfu226 crossref_primary_10_1016_j_snb_2020_128372 crossref_primary_10_3389_fphar_2020_00987 crossref_primary_10_1016_j_ajem_2017_09_017 crossref_primary_10_1016_j_semnephrol_2019_06_002 crossref_primary_10_1038_ki_2009_502 crossref_primary_10_1186_s13054_018_2090_1 crossref_primary_10_1097_MD_0000000000005112 crossref_primary_10_1186_s40560_018_0308_6 crossref_primary_10_33549_physiolres_935336 crossref_primary_10_1038_ki_2011_160 crossref_primary_10_1007_s00228_019_02792_0 crossref_primary_10_1093_ndt_gfq176 crossref_primary_10_14814_phy2_70203 crossref_primary_10_1007_s00134_023_07138_0 crossref_primary_10_5847_wjem_j_issn_1920_8642_2012_04_007 crossref_primary_10_1007_s11255_020_02555_2 crossref_primary_10_1016_j_ajem_2014_12_013 crossref_primary_10_1186_s13054_017_1807_x crossref_primary_10_1016_j_jcrc_2019_07_008 crossref_primary_10_1016_j_ccc_2020_11_010 crossref_primary_10_1056_NEJMoa1803213 crossref_primary_10_1016_j_cpem_2014_04_005 crossref_primary_10_1164_rccm_201502_0329OC crossref_primary_10_1007_s13546_010_0029_x crossref_primary_10_1080_0886022X_2022_2162415 crossref_primary_10_1007_s00134_012_2634_9 crossref_primary_10_1016_S0140_6736_11_61454_2 crossref_primary_10_7861_clinmedicine_18_1_47 crossref_primary_10_1186_s13054_016_1212_x crossref_primary_10_1016_j_ijcard_2016_12_130 crossref_primary_10_1089_ars_2016_6654 crossref_primary_10_1016_j_jcrc_2012_10_007 crossref_primary_10_1007_s10157_014_1076_9 crossref_primary_10_1007_s11560_022_00624_4 crossref_primary_10_1038_s41598_025_16081_7 crossref_primary_10_1016_j_burns_2010_03_018 crossref_primary_10_1080_0886022X_2024_2443026 crossref_primary_10_3389_fmed_2024_1500995 crossref_primary_10_1093_ckj_sfae412 crossref_primary_10_3390_jcm12031018 crossref_primary_10_1016_j_jcrc_2020_09_001 crossref_primary_10_14814_phy2_15453 crossref_primary_10_1161_STROKEAHA_120_030272 crossref_primary_10_1097_CNQ_0000000000000070 crossref_primary_10_1016_j_jinf_2015_11_008 crossref_primary_10_1093_jac_dkaf199 crossref_primary_10_1136_bmjopen_2023_074046 crossref_primary_10_1016_j_kint_2019_06_013 crossref_primary_10_1016_j_jemermed_2011_03_008 crossref_primary_10_1016_j_mpaic_2015_03_011 crossref_primary_10_1136_bmj_m4786 crossref_primary_10_1016_j_intimp_2018_02_023 crossref_primary_10_1080_09537104_2020_1817361 crossref_primary_10_1111_imm_12854 crossref_primary_10_1186_s12871_017_0312_8 crossref_primary_10_1097_MCC_0000000000000024 crossref_primary_10_1016_j_amjcard_2012_11_046 crossref_primary_10_1016_j_transproceed_2017_01_031 crossref_primary_10_3892_mmr_2017_8214 crossref_primary_10_1164_rccm_201504_0705LE crossref_primary_10_1007_s40620_019_00625_y crossref_primary_10_3389_fimmu_2018_03052 |
| Cites_doi | 10.1097/01.ASN.0000059863.48590.E9 10.1093/ndt/gfl541 10.1007/s00134-006-0232-4 10.1056/NEJMoa022139 10.1093/oxfordjournals.ndt.a027256 10.1097/00003246-198510000-00009 10.1097/00003246-199602000-00003 10.1038/sj.ki.5000440 10.1681/ASN.2005060668 10.1378/chest.98.1.170 10.1007/s001340000726 10.1001/jama.1995.03520260039030 10.1016/j.jcrc.2005.11.010 10.1097/00003246-200209000-00016 10.1001/archsurg.1973.01350160062010 10.1007/s00134-003-2121-4 10.1186/cc5735 10.1097/01.CCM.0000194725.48928.3A 10.1159/000102008 10.1186/cc3879 10.1097/00075198-200312000-00006 10.1159/000102080 10.1001/jama.294.7.813 10.1186/cc2872 10.1097/01.CCM.0000277041.13090.0A 10.2215/CJN.03681106 10.1097/01.CCM.0000050454.01978.3B 10.1097/00003246-200107000-00002 10.1001/jama.1993.03510240069035 10.1053/j.ajkd.2003.12.045 10.1186/cc5949 10.1093/ndt/gfm610 |
| ContentType | Journal Article |
| Copyright | Bagshaw et al.; licensee BioMed Central Ltd. 2008 COPYRIGHT 2008 BioMed Central Ltd. Copyright National Library of Medicine - MEDLINE Abstracts 2008 Copyright © 2008 Bagshaw et al.; licensee BioMed Central Ltd. 2008 Bagshaw et al.; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: Bagshaw et al.; licensee BioMed Central Ltd. 2008 – notice: COPYRIGHT 2008 BioMed Central Ltd. – notice: Copyright National Library of Medicine - MEDLINE Abstracts 2008 – notice: Copyright © 2008 Bagshaw et al.; licensee BioMed Central Ltd. 2008 Bagshaw et al.; licensee BioMed Central Ltd. |
| CorporateAuthor | the ANZICS Database Management Committee ANZICS Database Management Committee |
| CorporateAuthor_xml | – name: the ANZICS Database Management Committee – name: ANZICS Database Management Committee |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7QL C1K 7X8 5PM |
| DOI | 10.1186/cc6863 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic Bacteriology Abstracts (Microbiology B) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1364-8535 1466-609X |
| EndPage | R47 |
| ExternalDocumentID | PMC2447598 1506166301 A178102912 18402655 10_1186_cc6863 |
| Genre | Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
| GeographicLocations | New Zealand Australia United States |
| GeographicLocations_xml | – name: Australia – name: New Zealand – name: United States |
| GroupedDBID | --- 0R~ 29F 2WC 4.4 53G 5GY 5VS 6J9 6PF AAFWJ AAJSJ AASML AAWTL ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC C1A C6C CS3 DIK E3Z EBLON EBS EJD F5P GROUPED_DOAJ GX1 H13 HYE IAO IHR INH INR ITC KQ8 O5R O5S OK1 PIMPY PQQKQ RBZ ROL RPM RSV SJN SMD SOJ TR2 U2A WOQ YOC .6V AAYXX CITATION 7X7 88E 8FI 8FJ ABUWG AFKRA ALIPV BPHCQ BVXVI CCPQU CGR CUY CVF EBD ECM EIF EMOBN FYUFA HMCUK M1P NPM PHGZM PHGZT PJZUB PPXIY PROAC PSQYO SV3 UKHRP K9. 7QL C1K 7X8 5PM |
| ID | FETCH-LOGICAL-c559t-940a61339aaff87fbac53eb394bc6e4adb7f0625b7854b00d6242ea28c0e60f73 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 446 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000257632900019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1364-8535 1466-609X |
| IngestDate | Thu Aug 21 14:10:13 EDT 2025 Thu Sep 04 19:23:38 EDT 2025 Tue Oct 07 09:36:51 EDT 2025 Mon Oct 06 18:35:26 EDT 2025 Mon Nov 24 15:43:54 EST 2025 Mon Jul 21 05:55:03 EDT 2025 Tue Nov 18 20:25:00 EST 2025 Sat Nov 29 06:01:28 EST 2025 Sat Sep 06 07:29:37 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Urine Output Criterion Acute Kidney Injury Intensive Care Unit Admission Rifle Category Simplify Acute Physiology Score |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c559t-940a61339aaff87fbac53eb394bc6e4adb7f0625b7854b00d6242ea28c0e60f73 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://link.springer.com/10.1186/cc6863 |
| PMID | 18402655 |
| PQID | 195449412 |
| PQPubID | 44363 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2447598 proquest_miscellaneous_69266168 proquest_miscellaneous_19650360 proquest_journals_195449412 gale_infotracacademiconefile_A178102912 pubmed_primary_18402655 crossref_primary_10_1186_cc6863 crossref_citationtrail_10_1186_cc6863 springer_journals_10_1186_cc6863 |
| PublicationCentury | 2000 |
| PublicationDate | 2008-01-01 |
| PublicationDateYYYYMMDD | 2008-01-01 |
| PublicationDate_xml | – month: 01 year: 2008 text: 2008-01-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Critical care (London, England) |
| PublicationTitleAbbrev | Crit Care |
| PublicationTitleAlternate | Crit Care |
| PublicationYear | 2008 |
| Publisher | BioMed Central BioMed Central Ltd National Library of Medicine - MEDLINE Abstracts |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: National Library of Medicine - MEDLINE Abstracts |
| References | GS Martin (6296_CR29) 2003; 348 EA Hoste (6296_CR13) 2003; 14 JL Vincent (6296_CR17) 2006; 34 I Yegenaga (6296_CR18) 2004; 43 C Langenberg (6296_CR20) 2006; 21 E Licari (6296_CR21) 2007; 156 MM Levy (6296_CR25) 2003; 31 R Bellomo (6296_CR22) 2007; 156 C Brun-Buisson (6296_CR30) 2004; 30 M Brenner (6296_CR33) 1990; 98 PG Metnitz (6296_CR3) 2002; 30 M Oppert (6296_CR16) 2008; 23 JA Lopes (6296_CR14) 2007; 11 M Korkeila (6296_CR2) 2000; 26 F Rector (6296_CR32) 1972; 23 SM Bagshaw (6296_CR5) 2007 SM Bagshaw (6296_CR7) 2007; 11 J Le Gall (6296_CR28) 1993; 270 S Uchino (6296_CR4) 2005; 294 MS Rangel-Frausto (6296_CR11) 1995; 273 L Wan (6296_CR19) 2003; 9 FG Brivet (6296_CR35) 1996; 24 SM Bagshaw (6296_CR12) 2007; 2 H Neveu (6296_CR15) 1996; 11 R Bellomo (6296_CR24) 2004; 8 JL Xue (6296_CR8) 2006; 17 6296_CR26 CE Lucas (6296_CR31) 1973; 106 SM Bagshaw (6296_CR1) 2005; 9 PJ Stow (6296_CR23) 2006; 21 C Langenberg (6296_CR9) 2006; 69 M Ostermann (6296_CR6) 2007; 35 DC Angus (6296_CR10) 2001; 29 WA Knaus (6296_CR27) 1985; 13 L Wan (6296_CR34) 2006; 32 7799491 - JAMA. 1995 Jan 11;273(2):117-23 12660337 - J Am Soc Nephrol. 2003 Apr;14(4):1022-30 15312219 - Crit Care. 2004 Aug;8(4):R204-12 4696717 - Arch Surg. 1973 Apr;106(4):444-9 8254858 - JAMA. 1993 Dec 22-29;270(24):2957-63 16641923 - Kidney Int. 2006 Jun;69(11):1996-2002 2361386 - Chest. 1990 Jul;98(1):170-9 16769456 - J Crit Care. 2006 Jun;21(2):133-41 17464109 - Contrib Nephrol. 2007;156:1-9 12700374 - N Engl J Med. 2003 Apr 17;348(16):1546-54 8605788 - Crit Care Med. 1996 Feb;24(2):192-8 14639069 - Curr Opin Crit Care. 2003 Dec;9(6):496-502 3928249 - Crit Care Med. 1985 Oct;13(10):818-29 17466080 - Crit Care. 2007;11(2):411 16495381 - J Am Soc Nephrol. 2006 Apr;17(4):1135-42 17699448 - Clin J Am Soc Nephrol. 2007 May;2(3):431-9 8700363 - Nephrol Dial Transplant. 1996 Feb;11(2):293-9 16280066 - Crit Care. 2005;9(6):R700-9 14997295 - Intensive Care Med. 2004 Apr;30(4):580-8 11271091 - Intensive Care Med. 2000 Dec;26(12):1824-31 16775719 - Intensive Care Med. 2006 Aug;32(8):1238-42 17588270 - Crit Care. 2007;11(3):R68 17962378 - Nephrol Dial Transplant. 2008 Apr;23(4):1203-10 18065435 - Nephrol Dial Transplant. 2008 Mar;23(3):904-9 4671024 - Surg Forum. 1972;23(0):51-3 12352040 - Crit Care Med. 2002 Sep;30(9):2051-8 17581483 - Crit Care Med. 2007 Aug;35(8):1837-43; quiz 1852 11445675 - Crit Care Med. 2001 Jul;29(7):1303-10 12682500 - Crit Care Med. 2003 Apr;31(4):1250-6 15112172 - Am J Kidney Dis. 2004 May;43(5):817-24 17464124 - Contrib Nephrol. 2007;156:167-77 16106006 - JAMA. 2005 Aug 17;294(7):813-8 16424713 - Crit Care Med. 2006 Feb;34(2):344-53 16998215 - Nephrol Dial Transplant. 2006 Dec;21(12):3389-97 |
| References_xml | – volume: 14 start-page: 1022 year: 2003 ident: 6296_CR13 publication-title: J Am Soc Nephrol doi: 10.1097/01.ASN.0000059863.48590.E9 – volume: 21 start-page: 3389 year: 2006 ident: 6296_CR20 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfl541 – volume: 32 start-page: 1238 year: 2006 ident: 6296_CR34 publication-title: Intensive Care Med doi: 10.1007/s00134-006-0232-4 – volume: 348 start-page: 1546 year: 2003 ident: 6296_CR29 publication-title: N Engl J Med doi: 10.1056/NEJMoa022139 – volume: 11 start-page: 293 year: 1996 ident: 6296_CR15 publication-title: Nephrol Dial Transplant doi: 10.1093/oxfordjournals.ndt.a027256 – volume: 13 start-page: 818 year: 1985 ident: 6296_CR27 publication-title: Crit Care Med doi: 10.1097/00003246-198510000-00009 – volume: 24 start-page: 192 year: 1996 ident: 6296_CR35 publication-title: Crit Care Med doi: 10.1097/00003246-199602000-00003 – volume: 69 start-page: 1996 year: 2006 ident: 6296_CR9 publication-title: Kidney Int doi: 10.1038/sj.ki.5000440 – volume: 17 start-page: 1135 year: 2006 ident: 6296_CR8 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2005060668 – volume: 98 start-page: 170 year: 1990 ident: 6296_CR33 publication-title: Chest doi: 10.1378/chest.98.1.170 – volume: 26 start-page: 1824 year: 2000 ident: 6296_CR2 publication-title: Intensive Care Med doi: 10.1007/s001340000726 – volume: 273 start-page: 117 year: 1995 ident: 6296_CR11 publication-title: JAMA doi: 10.1001/jama.1995.03520260039030 – volume: 21 start-page: 133 year: 2006 ident: 6296_CR23 publication-title: J Crit Care doi: 10.1016/j.jcrc.2005.11.010 – volume: 30 start-page: 2051 year: 2002 ident: 6296_CR3 publication-title: Crit Care Med doi: 10.1097/00003246-200209000-00016 – volume: 106 start-page: 444 year: 1973 ident: 6296_CR31 publication-title: Arch Surg doi: 10.1001/archsurg.1973.01350160062010 – volume: 30 start-page: 580 year: 2004 ident: 6296_CR30 publication-title: Intensive Care Med doi: 10.1007/s00134-003-2121-4 – volume: 11 start-page: 411 year: 2007 ident: 6296_CR14 publication-title: Crit Care doi: 10.1186/cc5735 – volume: 34 start-page: 344 year: 2006 ident: 6296_CR17 publication-title: Crit Care Med doi: 10.1097/01.CCM.0000194725.48928.3A – volume: 156 start-page: 1 year: 2007 ident: 6296_CR22 publication-title: Contrib Nephrol doi: 10.1159/000102008 – volume: 9 start-page: R700 year: 2005 ident: 6296_CR1 publication-title: Crit Care doi: 10.1186/cc3879 – volume-title: Nephrol Dial Transplant year: 2007 ident: 6296_CR5 – volume: 9 start-page: 496 year: 2003 ident: 6296_CR19 publication-title: Curr Opin Crit Care doi: 10.1097/00075198-200312000-00006 – volume: 156 start-page: 167 year: 2007 ident: 6296_CR21 publication-title: Contrib Nephrol doi: 10.1159/000102080 – volume: 294 start-page: 813 year: 2005 ident: 6296_CR4 publication-title: JAMA doi: 10.1001/jama.294.7.813 – volume: 8 start-page: R204 year: 2004 ident: 6296_CR24 publication-title: Crit Care doi: 10.1186/cc2872 – volume: 35 start-page: 1837 year: 2007 ident: 6296_CR6 publication-title: Crit Care Med doi: 10.1097/01.CCM.0000277041.13090.0A – volume: 2 start-page: 431 year: 2007 ident: 6296_CR12 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.03681106 – volume: 31 start-page: 1250 year: 2003 ident: 6296_CR25 publication-title: Crit Care Med doi: 10.1097/01.CCM.0000050454.01978.3B – ident: 6296_CR26 – volume: 23 start-page: 51 year: 1972 ident: 6296_CR32 publication-title: Surg Forum – volume: 29 start-page: 1303 year: 2001 ident: 6296_CR10 publication-title: Crit Care Med doi: 10.1097/00003246-200107000-00002 – volume: 270 start-page: 2957 year: 1993 ident: 6296_CR28 publication-title: JAMA doi: 10.1001/jama.1993.03510240069035 – volume: 43 start-page: 817 year: 2004 ident: 6296_CR18 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2003.12.045 – volume: 11 start-page: R68 year: 2007 ident: 6296_CR7 publication-title: Crit Care doi: 10.1186/cc5949 – volume: 23 start-page: 904 year: 2008 ident: 6296_CR16 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfm610 – reference: 4671024 - Surg Forum. 1972;23(0):51-3 – reference: 11445675 - Crit Care Med. 2001 Jul;29(7):1303-10 – reference: 16424713 - Crit Care Med. 2006 Feb;34(2):344-53 – reference: 14997295 - Intensive Care Med. 2004 Apr;30(4):580-8 – reference: 12682500 - Crit Care Med. 2003 Apr;31(4):1250-6 – reference: 16495381 - J Am Soc Nephrol. 2006 Apr;17(4):1135-42 – reference: 12700374 - N Engl J Med. 2003 Apr 17;348(16):1546-54 – reference: 14639069 - Curr Opin Crit Care. 2003 Dec;9(6):496-502 – reference: 17962378 - Nephrol Dial Transplant. 2008 Apr;23(4):1203-10 – reference: 15312219 - Crit Care. 2004 Aug;8(4):R204-12 – reference: 8605788 - Crit Care Med. 1996 Feb;24(2):192-8 – reference: 17588270 - Crit Care. 2007;11(3):R68 – reference: 4696717 - Arch Surg. 1973 Apr;106(4):444-9 – reference: 16641923 - Kidney Int. 2006 Jun;69(11):1996-2002 – reference: 16998215 - Nephrol Dial Transplant. 2006 Dec;21(12):3389-97 – reference: 16775719 - Intensive Care Med. 2006 Aug;32(8):1238-42 – reference: 11271091 - Intensive Care Med. 2000 Dec;26(12):1824-31 – reference: 17699448 - Clin J Am Soc Nephrol. 2007 May;2(3):431-9 – reference: 18065435 - Nephrol Dial Transplant. 2008 Mar;23(3):904-9 – reference: 17464109 - Contrib Nephrol. 2007;156:1-9 – reference: 17466080 - Crit Care. 2007;11(2):411 – reference: 17581483 - Crit Care Med. 2007 Aug;35(8):1837-43; quiz 1852 – reference: 2361386 - Chest. 1990 Jul;98(1):170-9 – reference: 16106006 - JAMA. 2005 Aug 17;294(7):813-8 – reference: 17464124 - Contrib Nephrol. 2007;156:167-77 – reference: 16769456 - J Crit Care. 2006 Jun;21(2):133-41 – reference: 7799491 - JAMA. 1995 Jan 11;273(2):117-23 – reference: 12660337 - J Am Soc Nephrol. 2003 Apr;14(4):1022-30 – reference: 3928249 - Crit Care Med. 1985 Oct;13(10):818-29 – reference: 12352040 - Crit Care Med. 2002 Sep;30(9):2051-8 – reference: 15112172 - Am J Kidney Dis. 2004 May;43(5):817-24 – reference: 8700363 - Nephrol Dial Transplant. 1996 Feb;11(2):293-9 – reference: 8254858 - JAMA. 1993 Dec 22-29;270(24):2957-63 – reference: 16280066 - Crit Care. 2005;9(6):R700-9 |
| SSID | ssj0017863 |
| Score | 2.4629385 |
| Snippet | Introduction
We conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis.
Methods
The... We conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis. The study was a... We conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis. The study was a... Introduction We conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis. Methods The... We conducted a study to evaluate the incidence, risk factors and outcomes associated with early acute kidney injury (AKI) in sepsis.INTRODUCTIONWe conducted a... |
| SourceID | pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | R47 |
| SubjectTerms | Acute Kidney Injury - complications Acute Kidney Injury - epidemiology Adult APACHE Australia - epidemiology Care and treatment Complications and side effects Critical Care Medicine Emergency Medicine Female Hospital Mortality Humans Incidence Intensive Intensive Care Units - statistics & numerical data Kidney diseases Length of Stay - statistics & numerical data Logistic Models Male Medicine Medicine & Public Health Middle Aged New Zealand - epidemiology Retrospective Studies Risk Factors Sepsis Sepsis - complications Sepsis - epidemiology Statistics, Nonparametric Treatment Outcome |
| Title | Early acute kidney injury and sepsis: a multicentre evaluation |
| URI | https://link.springer.com/article/10.1186/cc6863 https://www.ncbi.nlm.nih.gov/pubmed/18402655 https://www.proquest.com/docview/195449412 https://www.proquest.com/docview/19650360 https://www.proquest.com/docview/69266168 https://pubmed.ncbi.nlm.nih.gov/PMC2447598 |
| Volume | 12 |
| WOSCitedRecordID | wos000257632900019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: RBZ dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1364-8535 dateEnd: 20231231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: DOA dateStart: 19980101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVAVX databaseName: Springer Link Journals customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: RSV dateStart: 19970401 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB4VWlVcoJQWUujiQ6ueIrx5-NEDElRFvYAqWtCql2jiOGoABUR2kfj3jJ1kl90K0Usu_mSNbE9mxjP-BuAT8kijiaPQiLQIE5QF6dwwDo0eJpZLXSAvfLMJeXKiRiP9s7vvaPpq9z4l6f_UXq2V2DNGKBEvwUsycco1aTj9dT7NF0ga6joHzbBzpmbxh_vI4ixWQy6kRL2lOVr7fxnfwGrnTbKDdvvX4YWt38Lr4y5fvgH7nr-YoZmMLbusitres6q-oHVkWBessTdN1XxlyHxdoRfNshkB-Ds4O_r--9uPsOuYEBqKDMahTjiSfY41YlkqWeZo0pjCZZ3kRtgEi1yWnCKeXKo0IYUr3OsQi5Ey3Apeyvg9LNfXtd0CVmouUCOBck_i5kCY5uSQKWPRlgF87hc3Mx2duOtqcZX5sEKJrF2MAHanuJuWQOMfxBe3N5nTKJrBYPcwgORw3FTZAe0uuUF6GAWw3W9f1qlakznKukQnbnR3Oko64hIfWNvriYOQHxoL_jRCaOeoCBXAZnsYZrJSBByJNA1Azh2TKcDxc8-P1NVfz9MdeTJFmpP1h-WR1HNL8OF5yDastKUq7vZnB5bHtxP7EV6Zu3HV3A5gSY7UwF8o0Pf08M_A68cDaXYO3A |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VgigXXuURCqwPVD1F9SaOHz0gVYiqiHaFoEW9RRPHEaEorZpdJP59x06y212Eynk-WSOPxzPjsT8DvEOeGLRpEluZlbFAVZLPjdPYmrFwXJkSeRk-m1CTiT47M1_68452uO0-tCTDTh3cWstda6WW6R24KyhKeZb8r9--z_sFikT9z0EL7FKoWd1wb0Sc1duQKy3REGkOHv2_jo_hYZ9Nsv3O_E9gzTVP4f5x3y_fhPeBv5ihnU0dO6_Lxv1hdfOT5pFhU7LWXbZ1u8eQhXuFQTXHFgTgz-D04OPJh8O4_zEhtlQZTGMjOFJ8Tg1iVWlVFWizlMplIworncCyUBWniqdQOhPkcKV_HeIw0ZY7ySuVPof15qJxL4FVhks0SKAikLh5EGYFJWTaOnRVBNvD5Oa2pxP3v1r8ykNZoWXeTUYEoznusiPQ-Aux422Te4-iESz2DwNID89Nle-TdSkNMuMkgq3BfHnvam3uKeuEEV46mkvJR3zjAxt3MfMQykNTyf-NkMYnKlJH8KJbDAtdqQJOZJZFoJaWyRzg-bmXJU39I_B0J4FMkcZkw2K5ofXSFLy6HTKCjcOT46P86NPk8xY86K6t-JOg17A-vZq5N3DP_p7W7dXb4BnXEe0O1A |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BQRUXyqsQCqwPIE5RvYnjRw-VqsIKBKwq8VBv0cR2RAC5qyaLxL_HdpLd7iKExHk-WaOxJ57JzHwGeI40U6jzLNW8MClDYbzPTfNUqymzVCiD1MTHJsR8Ls_P1dkwFNaO3e5jSbKfaQgsTa47XJi6d3HJD7XmkufX4QYLzfMhR__4ZVU7EF40vCK0xm5cO9sf3yu3z3Zn5FZ5NN46s73_0_cO3B6iTHLSH4u7cM26e7D7Yaij34fjyGtMUC87S743xtlfpHHfvH0JOkNau2ib9oggif2GUU1L1sTgD-Dz7PWn0zfp8JJCqn3G0KWKUfT3dq4Q61qKukJd5D6NVqzS3DI0laipz4QqIQvmHdGEqRGLmdTUclqLfB923IWzj4DUinJU6EFVJHcLICwqH6hJbdHWCbwYDV3qgWY8vHbxo4zphuRlb4wEJivcoifW-APxMuxTGTzNr6BxGBjwegTOqvLE77QPj9Q0S-Bg3MpycMG2DFR2TLEgnayk3ndCQQSdvVgGiI9Pc07_juAqBDBcJvCwPxhrXX1mnPGiSEBsHJkVIPB2b0pc8zXyd2eRZNGvScaDc0XrDRM8_jdkArtnr2bl-7fzdwdwq-9mCT-InsBOd7m0T-Gm_tk17eWz6CS_AUEzF7g |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Early+acute+kidney+injury+and+sepsis%3A+a+multicentre+evaluation&rft.jtitle=Critical+care+%28London%2C+England%29&rft.au=Bagshaw%2C+Sean+M&rft.au=George%2C+Carol&rft.au=Bellomo%2C+Rinaldo&rft.date=2008-01-01&rft.pub=National+Library+of+Medicine+-+MEDLINE+Abstracts&rft.issn=1364-8535&rft.eissn=1466-609X&rft.volume=12&rft.issue=2&rft.spage=R47&rft_id=info:doi/10.1186%2Fcc6863&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=1506166301 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-8535&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-8535&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-8535&client=summon |